Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Kalhan

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Opinion in Lipidology|December 27, 2019
Therapy and clinical trialsAtul Kalhan
Current Opinion in Lipidology|March 19, 2011
Statin/ezetimibe combination therapy: emerging evidenceAtul Kalhan, Alan Rees
Current Opinion in Lipidology|July 9, 2014
Novel cardiovascular risk-assessment metrics and absolute risk assessment: future role in clinical practice?Atul Kalhan, Alan Rees
Current Opinion in Lipidology|September 6, 2013
A potential role for monoclonal antibodies in clinical lipidology: can we look beyond statins?Atul Kalhan, Alan Rees
Current Opinion in Lipidology|July 18, 2012
Estimation of cardiovascular risk using 10-year risk metric: time for a rethink?Atul Kalhan, Alan Rees
Endocrinology, Diabetes & Metabolism Case Reports|May 2, 2017
Delayed dyskinesia and prolonged psychosis in a patient presenting with profound hyponatraemiaVictoria John, Philip Evans, Atul Kalhan
JPMA. the Journal of the Pakistan Medical Association|June 10, 2020
Long term complications and rehabilitation of COVID-19 patientsArundhati Dasgupta, Atul Kalhan, Sanjay Kalra
Expert Review of Endocrinology & Metabolism|June 20, 2020
New testosterone 2% gel using Ferring Advanced Skin Technology (FAST), for the treatment of testosterone deficiency in men, with a novel applicatorMichael Kirby, Atul Kalhan, Geoffrey Hackett
European Endocrinology|October 29, 2020
Testosterone in COVID-19 - Foe, Friend or Fatal Victim?Sanjay Kalra, Saptarshi Bhattacharya, Atul Kalhan
British Journal of Hospital Medicine (London, England : 2005)|February 1, 2020
Vitamin D and obesity in adults: a pathophysiological and clinical updateJulien Feghaly, Paul Johnson, Atul Kalhan
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Lipidology|December 27, 2019
Therapy and clinical trialsAtul Kalhan
Current Opinion in Lipidology|March 19, 2011
Statin/ezetimibe combination therapy: emerging evidenceAtul Kalhan, Alan Rees
Current Opinion in Lipidology|July 9, 2014
Novel cardiovascular risk-assessment metrics and absolute risk assessment: future role in clinical practice?Atul Kalhan, Alan Rees
Current Opinion in Lipidology|September 6, 2013
A potential role for monoclonal antibodies in clinical lipidology: can we look beyond statins?Atul Kalhan, Alan Rees
Current Opinion in Lipidology|July 18, 2012
Estimation of cardiovascular risk using 10-year risk metric: time for a rethink?Atul Kalhan, Alan Rees
Endocrinology, Diabetes & Metabolism Case Reports|May 2, 2017
Delayed dyskinesia and prolonged psychosis in a patient presenting with profound hyponatraemiaVictoria John, Philip Evans, Atul Kalhan
JPMA. the Journal of the Pakistan Medical Association|June 10, 2020
Long term complications and rehabilitation of COVID-19 patientsArundhati Dasgupta, Atul Kalhan, Sanjay Kalra
Expert Review of Endocrinology & Metabolism|June 20, 2020
New testosterone 2% gel using Ferring Advanced Skin Technology (FAST), for the treatment of testosterone deficiency in men, with a novel applicatorMichael Kirby, Atul Kalhan, Geoffrey Hackett
European Endocrinology|October 29, 2020
Testosterone in COVID-19 - Foe, Friend or Fatal Victim?Sanjay Kalra, Saptarshi Bhattacharya, Atul Kalhan
British Journal of Hospital Medicine (London, England : 2005)|February 1, 2020
Vitamin D and obesity in adults: a pathophysiological and clinical updateJulien Feghaly, Paul Johnson, Atul Kalhan
Pageof 3